Lisa Harrington

Riette Van Laack is speaking at ACI’s Legal, Regulatory, and Compliance Forum on Cosmetics & Personal Care Products ConferenceMarch 28th, 2023
Ricardo Carvajal is a moderator at FDLI’s Food and Dietary Supplement Safety and Regulation Conference (Virtual Event)March 24th, 2023
Larry Houck is speaking at American Pharmacists Annual MeetingMarch 24th, 2023
HPM Webinar: The “End” of the COVID-19 Emergency: the Ryan Haight Act, Telemedicine and Next StepsMarch 23rd, 2023
Kurt Karst is Co-Chair of FDA Bootcamp – Training in Core Regulatory Concepts for Life Sciences Attorneys, Business Executives, and Policy AnalystsMarch 22nd, 2023
Riette Van Laack is speaking at FDLI Introduction to Food Law and Regulation CourseMarch 22nd, 2023
Ricardo Carvajal is speaking at FDLI Introduction to Food Law and Regulation CourseMarch 21st, 2023
Doug Farquhar is speaking at Pharma Conference’s Current Hot GMP TopicsFebruary 8th, 2023
Frank Sasinowski will be panelist in Webinar: 2023 Wow! or Yeow!? FDA Outlook for 2023 and BeyondJanuary 20th, 2023
Anne Walsh is speaking at FDLI’s Enforcement, Litigation, and Compliance Conference: For the Drug, Device, Food, and Tobacco IndustriesDecember 7th, 2022
Frank Sasinowski is speaking at the Milken Institute Partnering for Patients Forum 2022December 6th, 2022
Sara Koblitz is speaking at GRx+Bioxims 2022 Generics and Biosimilars ConferenceNovember 8th, 2022
Kurt Karst is speaking at GRx+Biosims 2022 Generics and Biosimilars ConferenceNovember 8th, 2022
Anne Walsh is speaking at International Bar Association Annual ConferenceNovember 3rd, 2022
Sara Koblitz is speaking at Food and Drug Law Journal 2022 Symposium – “The Interconnected Regulatory Landscape: Exploring FDA’s Relationship with Other Domestic Regulators”November 3rd, 2022
Sara Koblitz is speaking at ACI’s Virtual Series: Hatch-Waxman and BPCIA Passport to Proficiency Series: Focus on Bioequivalence, Exclusivity, Extensions, and Exceptions;October 25th, 2022
Ricardo Carvajal is speaking at FEMA Fall SymposiumOctober 24th, 2022
Sara Koblitz is presenting at TOPRA Virtual Masterclass: Module Regulatory Strategy for Established Active SubstancesOctober 13th, 2022
Kurt Karst is speaking at World Intellectual Property ForumOctober 10th, 2022
Ricardo Carvajal is speaking at FDLI’s Food Advertising, Labeling, and Litigation Conference: For the Food and Dietary Supplement IndustriesSeptember 28th, 2022
Ricardo Carvajal is speaking at FDLI Lunch and Learn: Practicing Food Law Today: What You Must KnowSeptember 27th, 2022
Kurt Karst is speaking at ACI’s Paragraph IV Disputes Master SymposiumSeptember 21st, 2022
Deborah Livornese is participating in FDANews WebinarSeptember 15th, 2022
Kurt Karst is Co-Chair at ACI’s Virtual FDA Boot CampSeptember 14th, 2022
Adrienne Lenz is speaking at RAPS Convergence 2022September 13th, 2022
Karla Palmer is participating in FDLI WebinarAugust 30th, 2022
Riette van Laack is speaking at IFT First Annual Event and ExpoJuly 10th, 2022
Anne Walsh is speaking at FDLI’s Annual Conference: Exploring Advanced Topics in Food and Drug LawJune 15th, 2022
Sara Koblitz is speaking at FDLI’s Annual Conference: Exploring Advanced Topics in Food and Drug LawJune 15th, 2022
Ricardo Carvajal is speaking at FDLI’s Annual Conference: Exploring Advanced Topics in Food and Drug LawJune 15th, 2022
Allyson Mullen is speaking at SAGES 16th International NOSCAR Summit and Surgical Disruptive Technology SummitJune 11th, 2022
Frank Sasinowski is speaking at The United Mitochondrial Disease Foundation ConferenceJune 9th, 2022
Sophia Gaulkin is speaking at ACI’s Advanced Summit on Life Sciences PatentJune 2nd, 2022
Faraz Siddiqui is taking part in University of Minnesota, Carlson School of Management, WebinarMay 17th, 2022
Allyson Mullen is speaking at AMCP eLearning Days ConferenceMay 11th, 2022
Charles Raver is speaking at FDLI’s Introduction to Drug Law and Regulation Course (Virtual)April 27th, 2022
Allyson Mullen is speaking at AMDM 2022 IVD Regulatory MeetingApril 27th, 2022
Kurt Karst is speaking at ACI’s Paragraph IV Disputes ConferenceApril 26th, 2022
James R. Phelps: 1938 – 2022April 4th, 2022
April 4, 2022 With great sadness, we announce that our firm’s co-founder, leader, colleague and friend, Jim Phelps passed away on April 2, 2022, at the age of 83. Jim is survived by Sophia, his wife of 57 years, his three sons and their wives, Evan …
Kurt Karst is speaking at ACI’s FDA Boot CampMarch 23rd, 2022
Dara Levy is speaking at DIA’s Advertising and Promotion Regulatory Affairs ConferenceMarch 8th, 2022
Former FDAer Dr. Ellis F. Unger Joins Hyman, Phelps & McNamara, P.C. as Principal Drug Regulatory ExpertFebruary 24th, 2022
Hyman, Phelps & McNamara, P.C. (“HP&M”) is pleased and excited to announce that Dr. Ellis F. Unger has joined the firm as a Principal Drug Regulatory Expert. Dr. Unger is a cardiologist and former Director of the Office of Drug Evaluation-I in FDA’s Office of …
Frank Sasinowski and Karin Moore are participating in Webinar, Wow or Yeow?! FDA Outlook for 2022 and BeyondJanuary 28th, 2022
Frank Sasinowski is speaking at University of Rochester School of Medicine, Department of Neurology Working Group SeminarJanuary 21st, 2022
Jeff Gibbs is participating in FDANews Webinar, “The Biden Administration’s FDA: A Remarkable 2021, What to Expect in 2022”January 20th, 2022
Adrienne Lenz is speaking at Life Science Regulatory Intelligence ConferenceJanuary 18th, 2022
Congratulations to HP&M’s first Principal Medical Device Regulation Expert, Adrienne LenzJanuary 6th, 2022
January 6, 2022 Hyman, Phelps & McNamara, P.C. (HP&M) is pleased to announce Adrienne R. Lenz has become its first Principal Medical Device Regulation Expert. Adrienne joined HPM in September 2017. In her time with HPM, she has made significant contributions to the firm and its clients. Prior …
HP&M Promotes Sara Koblitz to DirectorJanuary 6th, 2022
January 6, 2022 Hyman, Phelps & McNamara, P.C. (HP&M) is pleased to announce that Sara W. Koblitz has become the firm’s newest Director. Sara’s practice covers the intersection of FDA regulatory issues and Intellectual Property, including the Hatch-Waxman Amendments, the Biologics Price Competition and Innovation Act, and the …
Kurt Karst is Co-Chair of ACI’s FDA Boot Camp (Virtual Event)December 28th, 2021
Kurt Karst is speaking at ACI’s Paragraph IV Disputers ConferenceNovember 9th, 2021